Correction of the enzymic defect in cultured fibroblasts from patients with Fabry's disease: treatment with purified alpha-galactosidase from ficin.
D002247:Carbon Isotopes; D002478:Cells, Cultured; D002518:Ceramides / Q000378:metabolism; D002855:Chromatography, Thin Layer; D005347:Fibroblasts / Q000187:drug effects / Q000201:enzymology*; D005696:Galactosidases / Q000378:metabolism / Q000627:therapeutic use*; D006017:Glycolipids / Q000378:metabolism*; D006801:Humans; D066298:In Vitro Techniques; D008052:Lipid Metabolism, Inborn Errors / Q000188:drug therapy / Q000201:enzymology*; D008247:Lysosomes / Q000378:metabolism; D008722:Methods; D010944:Plants / Q000201:enzymology; D012867:Skin / Q000187:drug effects / Q000201:enzymology*; D013577:Syndrome; D013997:Time Factors
D002247:Carbon Isotopes; D002518:Ceramides; D006017:Glycolipids; D005696:Galactosidases